$1.34
-0.015-1.1%
마지막 업데이트: Oct 22, 9:32 AM
$1.33
-0.0326-2.4%
Benzinga
Benzinga
Benzinga
목요일, 10월 22
Benzinga
© 2026 Benzinga | All Rights Reserved
Anavex Life Sciences (AVXL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.08 | $-0.07 | $-0.11 | $-0.14 |
| Actual | $0.08 | $-0.06 | $-0.06 | $-0.11 |
| Surprise | +200.0% | +14.3% | +45.5% | +21.4% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | — | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.11 | $-0.12 | $-0.14 |
| Revenue | |||
| Consensus | — | — | — |
| 회계 분기 | 보고된 날짜 | 실제 EPS | 예상 EPS | 놀라다 % |
|---|---|---|---|---|
| Q3 | Aug 25, 2026 | $0.08 | $-0.08 | 200.0 % |
| Q2 | Jul 30, 2026 | $-0.06 | $-0.07 | 14.3 % |
| Q1 | Feb 9, 2026 | $-0.06 | $-0.11 | 45.5 % |
| Q4 | Nov 25, 2025 | $-0.11 | $-0.14 | 21.4 % |